MOON vs. GERM ETF Comparison
Comparison of Direxion Moonshot Innovators ETF (MOON) to ETFMG Treatments Testing and Advancements ETF (GERM)
MOON
Direxion Moonshot Innovators ETF
MOON Description
The Direxion Moonshot Innovators ETF offers exposure to the 50 most innovate US companies at the forefront of changing our lives today, and tomorrow, by identifying the companies both pursuing innovation, and having the potential to disrupt existing technologies and/or industries. These 50 companies selected for inclusion are deemed to have the highest "early-stage composite innovation scores" and the they span themes and emerging sectors such as smart transportation, clean power, and the human evolution. The early stage composite score is based on a company’s "allocation to innovation" and "innovation sentiment" score.
Grade (RS Rating)
Last Trade
$10.33
Average Daily Volume
18,830
10
GERM
ETFMG Treatments Testing and Advancements ETF
GERM Description
GERM is designed to give direct exposure to the biotech companies directly engaged in the testing and treatments of infectious diseases. Focused on advancements with targeted exposure to the forefront of R&D, vaccines, therapies and testing technologies.Grade (RS Rating)
Last Trade
$19.16
Average Daily Volume
1,248
2
Performance
Period | MOON | GERM |
---|---|---|
30 Days | 8.34% | 3.00% |
60 Days | 1.77% | 3.68% |
90 Days | 16.07% | -2.06% |
12 Months | -26.00% | -0.17% |
0 Overlapping Holdings
Symbol | Grade | Weight in MOON | Weight in GERM | Overlap |
---|
MOON: Top Represented Industries & Keywords
GERM: Top Represented Industries & Keywords